Literature DB >> 27467918

Tetraspanin CD81, a modulator of immune suppression in cancer and metastasis.

Felipe Vences-Catalán1, Ranjani Rajapaksa1, Minu K Srivastava1, Aurelien Marabelle1, Chiung-Chi Kuo1, Ronald Levy1, Shoshana Levy1.   

Abstract

Cancer cells can escape the antitumor immune response by recruiting immune suppressor cells. However, although innate myeloid-derived suppressor cells (MDSCs) and T regulatory (Treg) cells accumulate normally in tumor-bearing CD81-deficient mice, both populations are impaired in their ability to suppress the antitumor immune response.

Entities:  

Keywords:  CD81 knockout (CD81KO) mice; T regulatory (Treg) cells; myeloid-derived suppressor cells (MDSCs); tumor

Year:  2015        PMID： 27467918      PMCID： PMC4910756          DOI： 10.1080/2162402X.2015.1120399

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN： 2162-4011            Impact factor:   8.110


  10 in total

1.  Cutting edge: dynamic redistribution of tetraspanin CD81 at the central zone of the immune synapse in both T lymphocytes and APC.

Authors:  María Mittelbrunn; María Yáñez-Mó; David Sancho; Angeles Ursa; Francisco Sánchez-Madrid
Journal:  J Immunol       Date:  2002-12-15       Impact factor: 5.422

Review 2.  The future of immune checkpoint therapy.

Authors:  Padmanee Sharma; James P Allison
Journal:  Science       Date:  2015-04-03       Impact factor: 47.728

Review 3.  Tetraspanins: push and pull in suppressing and promoting metastasis.

Authors:  Margot Zöller
Journal:  Nat Rev Cancer       Date:  2008-12-11       Impact factor: 60.716

Review 4.  Tetraspanin-enriched microdomains: a functional unit in cell plasma membranes.

Authors:  María Yáñez-Mó; Olga Barreiro; Mónica Gordon-Alonso; Mónica Sala-Valdés; Francisco Sánchez-Madrid
Journal:  Trends Cell Biol       Date:  2009-08-24       Impact factor: 20.808

5.  New insights into the mechanism of action of immune checkpoint antibodies.

Authors:  Aurélien Marabelle; Holbrook Kohrt; Ronald Levy
Journal:  Oncoimmunology       Date:  2014-08-03       Impact factor: 8.110

Review 6.  Coordinated regulation of myeloid cells by tumours.

Authors:  Dmitry I Gabrilovich; Suzanne Ostrand-Rosenberg; Vincenzo Bronte
Journal:  Nat Rev Immunol       Date:  2012-03-22       Impact factor: 53.106

7.  CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency.

Authors:  Menno C van Zelm; Julie Smet; Brigitte Adams; Françoise Mascart; Liliane Schandené; Françoise Janssen; Alina Ferster; Chiung-Chi Kuo; Shoshana Levy; Jacques J M van Dongen; Mirjam van der Burg
Journal:  J Clin Invest       Date:  2010-03-08       Impact factor: 14.808

Review 8.  Function of the tetraspanin molecule CD81 in B and T cells.

Authors:  Shoshana Levy
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

9.  Tetraspanin CD81 promotes tumor growth and metastasis by modulating the functions of T regulatory and myeloid-derived suppressor cells.

Authors:  Felipe Vences-Catalán; Ranjani Rajapaksa; Minu K Srivastava; Aurelien Marabelle; Chiung-Chi Kuo; Ronald Levy; Shoshana Levy
Journal:  Cancer Res       Date:  2015-09-01       Impact factor: 12.701

10.  Normal lymphocyte development but delayed humoral immune response in CD81-null mice.

Authors:  H T Maecker; S Levy
Journal:  J Exp Med       Date:  1997-04-21       Impact factor: 14.307
  10 in total
  7 in total

1.  Increased expression of CD81 is associated with poor prognosis of prostate cancer and increases the progression of prostate cancer cells in vitro.

Authors:  Yu Zhang; Haining Qian; An Xu; Ganggang Yang
Journal:  Exp Ther Med       Date:  2019-11-26       Impact factor: 2.447

2.  Immune phenotype of the CD4+ T cells in the aged lymphoid organs and lacrimal glands.

Authors:  Claudia M Trujillo-Vargas; Kelsey E Mauk; Humberto Hernandez; Rodrigo G de Souza; Zhiyuan Yu; Jeremias G Galletti; Jana Dietrich; Friedrich Paulsen; Cintia S de Paiva
Journal:  Geroscience       Date:  2022-03-12       Impact factor: 7.713

Review 3.  Immune Targeting of Tetraspanins Involved in Cell Invasion and Metastasis.

Authors:  Felipe Vences-Catalán; Shoshana Levy
Journal:  Front Immunol       Date:  2018-06-12       Impact factor: 7.561

4.  Proteomic Comparison of Malignant Human Germ Cell Tumor Cell Lines.

Authors:  Felix Bremmer; Hanibal Bohnenberger; Stefan Küffer; Thomas Oellerich; Hubert Serve; Henning Urlaub; Arne Strauss; Yasmine Maatoug; Carl Ludwig Behnes; Christoph Oing; Heinz Joachim Radzun; Philipp Ströbel; Stefan Balabanov; Friedemann Honecker
Journal:  Dis Markers       Date:  2019-09-03       Impact factor: 3.434

5.  SHP-2 Interacts with CD81 and Regulates the Malignant Evolution of Colorectal Cancer by Inhibiting Epithelial-Mesenchymal Transition.

Authors:  Huaqin Yuan; Jun Zhao; Yang Yang; Rongfu Wei; Liangxue Zhu; Jie Wang; Meiqing Ding; Mingyun Wang; Yanhong Gu
Journal:  Cancer Manag Res       Date:  2020-12-23       Impact factor: 3.989

Review 6.  Exosomal Proteins and Lipids as Potential Biomarkers for Lung Cancer Diagnosis, Prognosis, and Treatment.

Authors:  Ming-Tsung Hsu; Yu-Ke Wang; Yufeng Jane Tseng
Journal:  Cancers (Basel)       Date:  2022-01-30       Impact factor: 6.639

7.  Suppression of CD81 promotes bladder cancer cell invasion through increased matrix metalloproteinase expression via extracellular signal-regulated kinase phosphorylation.

Authors:  Hyun Sik Park; Suhyuk Lee; Jisu Lee; Hyun Bin Shin; Seung-Min Yoo; Myung-Shin Lee; Jinsung Park
Journal:  Investig Clin Urol       Date:  2019-07-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.